Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2022-09-01 2022-09-23 168424
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2024-06-20 2024-11-22 231027
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2024-07-25 2024-11-22 233709
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2024-08-15 2025-02-07 235342
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2024-12-19 2025-01-17 246056
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2023-07-13 2023-12-22 198505
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-10-27 2024-02-09 208411
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2023-02-09 2023-09-22 184092
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Avoided shortage 2023-03-09 2023-09-15 186580
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-03-09 2023-09-22 186583
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-06-02 2023-06-29 193617
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2024-04-05 2024-04-19 224586
APO-PERINDOPRIL/AMLODIPINE 7MG 5MG TABLET Resolved 2020-04-22 2020-04-28 112741
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-09-15 2023-09-28 204424
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-10-20 2023-10-27 207704
APO-PERINDOPRIL/AMLODIPINE 5MG 7MG TABLET Resolved 2023-10-20 2023-10-27 207707
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-11-10 2024-02-09 209936
APO-PERINDOPRIL/AMLODIPINE 5MG 7MG TABLET Resolved 2023-11-24 2023-12-15 211490
APO-PERINDOPRIL/AMLODIPINE 2.5MG 3.5MG TABLET Resolved 2023-12-01 2023-12-15 212386
APO-PERINDOPRIL/AMLODIPINE 14MG 10MG TABLET Resolved 2020-08-19 2020-09-25 122486

Showing 2301 to 2320 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 359